Article
Should the world collaborate imminently to develop neglected live‐attenuated vaccines for COVID‐19?
15 Sept 2021
Abstract excerpt
The rapid spread of the Delta variant suggests that SARS-CoV-2 will likely be rampant for months or years and could claim millions of more lives. All the known vaccines cannot well defeat SARS-CoV-2 due to their limited efficacy and production efficiency, except for the neglected live-attenuated vaccines (LAVs), which could have a much higher efficacy and much higher production efficiency than other vaccines....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
